@FierceMedDev: ForSight Vision5 ropes in $15M in Series C financing to develop its intraocular therapy. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI yesterday: Abbott's device sales slip as diagnostics keeps revenue rolling. Story | Follow @VarunSaxena2
@EmilyWFierce: ICYMI yesterday: Boston Scientific scores FDA approval for a new crop of implantable cardiac devices. More | Follow @EmilyWFierce
@MichaelGFierce: MIT team delivers three ovarian cancer drugs with one particle. Story from FierceDrugDelivery | Follow @MichaelGFierce
> Provista Diagnostics raised $6 million in Series B cash to expand the market for its cancer tests. Story
> Danaher ($DHR) CEO H. Lawrence Culp will retire on March 1, 2015, to be replaced by current company President Thomas Joyce. News
> Breathe Technologies picked up FDA clearance to use its ventilation device on non-oxygen-dependent patients. More
Biotech News
@FierceBiotech: AMRI plans to shutter an R&D shop to save cash. Story from FierceCRO | Follow @FierceBiotech
@JohnCFierce: Pfizer, AstraZeneca back a new strategy for cancer drug R&D. Article | Follow @JohnCFierce
@DamianFierce: FDA sends out obscure notice that it'll discuss a "Safety Communication on the use of a device for a certain medical procedure" at 1. | Follow @DamianFierce
@EmilyMFierce: Latest WHO update on Ebola outbreak in Western Africa: 224 cases, including 135 deaths. More | Follow @EmilyMFierce
> GlaxoSmithKline and Galapagos succeed in psoriasis after two setbacks. More
> Biotech upstart grabs $18M to study a new drug to protect pregnancies. Report
> Vital Therapies banks $54M in a downsized IPO retry. Article
> Which therapies top Thomson Reuters' list of new drugs to watch this year? Story
Pharma News
@FiercePharma: Tops on FP yesterday: Novartis marks 235 admin jobs for deletion amid companywide restructuring. Story | Follow @FiercePharma
@TracyStaton: ICYMI: Juicy trade-secrets dispute between Bristol-Myers + its ad agency and an account manager who jumped ship. Report | Follow @TracyStaton
@EricPFierce: FDA says import alert for saline made at Baxter plant in Canada has no connection to shortage in U.S. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: Our newest special report is live! Top 10 M&A deals of 2013. Feature | Follow @CarlyHFierce
> GlaxoSmithKline steps up bribery probes, eyeing potential violations in 9 Middle Eastern countries. Report
> Under fire from local pharmas, China backs off price caps. More
Pharma Manufacturing News
> Novartis' Sandoz unit recalls some Ritalin over packaging issue. Article
> Bill for California statewide disposal law lands in the trash. Story
> Counterfeits of Roche's Herceptin found in EU supply chain. More
> Novartis' Alcon opens $160M plant in Singapore. News
> U.K. starts work on $64M biologics manufacturing center. Report
Vaccines News
> Ebola deaths rise to 135 as vaccine research lags. Report
> Merck, Sanofi hope for sales expansion with two-dose Gardasil switch. Story
> Whooping cough mutations may be weakening vaccine effectiveness. More
> New Novartis director will implement Bexsero on U.K. immunization program. Item
> Dynavax initiates PhIII study it hopes will quell FDA's safety concerns. Article